Thea is building the AI layer for aesthetics.
What’s happening: The dermatologist-grade skincare platform raised $4M in a pre-seed led by General Catalyst to expand across hair loss, anti-aging, and peptides.
Face time. Initially launched as an AI dermatology app, Thea analyzes user-submitted photos for acne, rosacea, visible aging while generating an overall skin health score. Uploading existing routines and products, users receive personalized recommendations based on compatibility, efficacy, and goals.
Matchmaker. Guided by a multimodal agentic assistant, users discuss symptoms, track progress, and refine protocols over time. Doubling as a discovery engine, they can explore condition-specific products, monitor pricing, and build personalized regimens through its shoppable database.
Combining diagnostics and commerce, Thea has scaled rapidly, eclipsing 500K users in under a year. Habit-forming, CEO Kevin Chiu says ~20% of users engage daily, submitting multiple photos per week and chatting with its agent for 15+ minutes.
AI doc. Evolving beyond analysis into care delivery, Thea is aligning with preventative dermatology and the longevity-meets-medspa boom — positioning itself as an “AI doctor for aesthetics.”
Closing the loop, it’s combining AI guidance with human clinicians, prescriptions, and same-day treatment spanning microdosed acutane, hair loss drug finasteride, anti-aging peptide GHK-CU, and more.
Building a HIPAA-compliant infrastructure, its platform will route users from AI recommendations to licensed dermatologists and integrated pharmacy partners as needed.
Punchline: Part clinician, part advisor, part shopping algo, Thea is scaling accessible, AI-native support for highly personal issues.
